December 1, 2021
Takeda Pharmaceutical launched its first cell therapy product Alofisel (darvadstrocel) in Japan for the treatment of complex perianal fistulas associated with Crohn’s disease (CD) on November 30. Alofisel is the company’s first therapy approved under the category of regenerative medicine...read more